Ion Exchange (india) Ltd. · NSE:IONEXCHANG
Ion Exchange (india) — Q2 FY23 Earnings Presentation
23 slides from Ion Exchange (india)'s earnings presentation, Nov 10, 2022
Slide 1: Covering letter to stock exchanges
November 10, 2022 To To BSE Limited National Stock Exchange of India Limited The Corporate Relationship Dept. Exchange Plaza, C-1, Block- G, P.J. Towers, Dalal Street Bandra Kurla Complex, Bandra (East), Mumbai-400 001 Mumbai-400 051 Scrip Code: 500214 Scrip Code: IONEXCHANG Sub: Submission of Analy
Slide 2: Earnings Presentation – Q2 / H1-FY23
EARNINGS PRESENTATION – Q2 / H1-FY23
Slide 3: Executive Summary
Executive Summary OVERVIEW • Ion Exchange (India) Ltd (Ion Exchange), formed in 1964, is a pioneer in water, waste water treatment & FY22: Operating environment solutions and caters to various industries, institutions, homes & communities. Income* • Headquartered in Mumbai, the company has seven man
Slide 4: Company Overview
Company Overview • Ion Exchange was originally formed as a subsidiary of Permutit, UK in 1964. It REVENUE BREAKUP (FY22)* became a wholly owned Indian company in 1985. The company is currently in its 59th Year of operations. • The company has expanded its footprints globally and possesses a diversif
Slide 5: Q2 / H1-FY23 Financial Highlights
Q2 / H1-FY23 Financial Highlights Q2-FY23 Performance (Standalone) Q2-FY23 Performance (Consolidated) INR 4,177 Mn INR 440 Mn 10.53% INR 4,476 Mn INR 533 Mn 11.91% Operating Income Operating EBITDA Operating EBITDA Operating Income Operating EBITDA Operating EBITDA Margins Margins INR 341 Mn 8.16% I
Slide 6: Q2 / H1-FY23 Operational Highlights
Q2 / H1-FY23 Operational Highlights ENGINEERING Ø The company witnessed steady order flows both in domestic and international market. Ø Regarding Sri Lanka order, the execution remained affected due to the ongoing uncertainties in Sri Lanka. Ø Execution of the UP Jal Nigam Project is progressing sat
Slide 7: Quarterly Standalone Financial Performance
Quarterly Standalone Financial Performance INCOME STATEMENT (INR MN) Q2-FY23 Q2-FY22 Y-o-Y Q1-FY23 Q-o-Q Operating Income 4,177 3,647 14.5% 3,580 16.7% Expenses 3,737 3,250 15.0% 3,251 14.9% Operating EBITDA 440 397 10.8% 329 33.7% Operating EBITDA Margins (%) 10.53% 10.89% (36) Bps 9.19% 134 Bps De
Slide 8: Quarterly Standalone Segmental Breakup
Quarterly Standalone Segmental Breakup ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 2,377 455 2,109 E 1,497 353 V 1,311 E N U E Q2-FY22 Q2-FY23 Q2-FY22 Q2-FY23 Q2-FY22 Q2-FY23 129 351 Q2-FY22 Q2-FY23 122 286 E B I (6) (6) T Q2-FY22 Q2-FY23 Q2-FY22 Q2-FY23 7
Slide 9: Half Yearly Standalone Financial Performance
Half Yearly Standalone Financial Performance INCOME STATEMENT (INR MN) H1-FY23 H1-FY22 Y-o-Y Operating Income 7,757 6,653 16.6% Expenses 6,987 5,891 18.6% Operating EBITDA 770 762 1.0% Operating EBITDA Margins (%) 9.93% 11.45% (152) Bps Depreciation 137 134 2.2% Finance Cost 32 40 (20.0)% Other Inco
Slide 10: Half Yearly Standalone Segmental Breakup
Half Yearly Standalone Segmental Breakup ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 4,236 3,832 E 959 2,875 V 2,471 E 589 N U E H1-FY22 H1-FY23 H1-FY22 H1-FY23 H1-FY22 H1-FY23 654 H1-FY22 H1-FY23 538 E 250 (3) B 220 I T (20) H1-FY22 H1-FY23 H1-FY22 H1-FY23 9
Slide 11: Quarterly Consolidated Financial Performance
Quarterly Consolidated Financial Performance INCOME STATEMENT (INR MN) Q2-FY23 Q2-FY22 Y-o-Y Q1-FY23 Q-o-Q Operating Income 4,476 3,782 18.4% 3,824 17.1% Expenses 3,943 3,385 16.5% 3,495 12.8% Operating EBITDA 533 397 34.3% 329 62.0% Operating EBITDA Margins (%) 11.91% 10.50% 141 Bps 8.60% 331 Bps D
Slide 12: Quarterly Consolidated Segmental Breakup
Quarterly Consolidated Segmental Breakup ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 2,577 455 E 2,208 1,595 353 V 1,347 E N U E Q2-FY22 Q2-FY23 Q2-FY22 Q2-FY23 Q2-FY22 Q2-FY23 182 Q2-FY22 Q2-FY23 377 E 131 283 B (5) (5) I T Q2-FY22 Q2-FY23 Q2-FY22 Q2-FY23 11
Slide 13: Half Yearly Consolidated Financial Performance
Half Yearly Consolidated Financial Performance INCOME STATEMENT (INR MN) H1-FY23 H1-FY22 Y-o-Y Operating Income 8,300 6,923 19.9% Expenses 7,438 6,168 20.6% Operating EBITDA 862 755 14.2% Operating EBITDA Margins (%) 10.39% 10.91% (52) Bps Depreciation 143 140 2.1% Finance Cost 45 52 (13.5)% Other I
Slide 14: Half Yearly Consolidated Segmental Breakup
Half Yearly Consolidated Segmental Breakup ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 4,601 3,975 960 E V 3,054 2,598 E 589 N U E H1-FY22 H1-FY23 H1-FY22 H1-FY23 H1-FY22 H1-FY23 H1-FY22 H1-FY23 262 690 E 222 555 (1) B I T (18) H1-FY22 H1-FY23 H1-FY22 H1-FY23 13
Slide 15: Historical Financial Overview
HISTORICAL FINANCIAL OVERVIEW 14
Slide 16: Historical Standalone Financial Performance
Historical Standalone Financial Performance INCOME STATEMENT (INR MN) FY19 FY20 FY21 FY22 H1-FY23 Operating Income 11,023 14,072 14,018 15,094 7,757 Expenses 10,110 12,862 12,067 13,123 6,987 Operating EBITDA 913 1,210 1,951 1,971 770 Operating EBITDA Margins (%) 8.28% 8.60% 13.92% 13.06% 9.93% Depr
Slide 17: Historical Standalone Balance Sheet
Historical Standalone Balance Sheet PARTICULARS (INR MN) FY21 FY22 H1-FY23 PARTICULARS (INR MN) FY21 FY22 H1-FY23 EQUITIES & LIABILITIES ASSETS Equity Non-Current Assets (A) Equity Share Capital 147 147 147 (A) Property, Plant and Equipment 1,421 1,389 1,410 6,123 7,527 8,049 (B) Capital Work-in-pro
Slide 18: Historical Consolidated Financial Performance
Historical Consolidated Financial Performance INCOME STATEMENT (INR MN) FY19 FY20 FY21 FY22 H1-FY23 Operating Income 11,623 14,798 14,495 15,769 8,300 Expenses 10,557 13,453 12,472 13,637 7,438 Operating EBITDA 1,066 1,345 2,023 2,132 862 Operating EBITDA Margins (%) 9.17% 9.09% 13.96% 13.52% 10.39%
Slide 19: Historical Consolidated Balance Sheet
Historical Consolidated Balance Sheet PARTICULARS (INR MN) FY21 FY22 H1-FY23 PARTICULARS (INR MN) FY21 FY22 H1-FY23 EQUITIES & LIABILITIES ASSETS Equity Non-Current Assets (A) Equity Share Capital 142 142 142 (A) Property, Plant and Equipment 1,486 1,446 1,469 (B) Other Equity 4,916 6,414 6,924 (B)
Slide 20: Consolidated Financial Performance
Consolidated Financial Performance REVENUES (INR MN) OPERATING EBITDA (INR MN) PAT (INR MN) REVENUE EBITDA PAT 15,769 CAGR 11% 2,132 CAGR 29% CAGR 42% 14,798 14,495 2,023 1,617 1,433 11,623 1,345 8,300 1,066 942 862 659 661 13.96% 13.52% 9.89% 10.25% 10.39% 7.96% 9.17% 9.09% 6.37% 5.67% FY19 FY20 FY
Slide 21: Market Data
Market Data (Bloomberg – ION IN, Reuters – IONX.BO) 1 YEAR SHARE PRICE MOVEMENT (UP TO 30th September, 2022) 10% 0% -10% -20% -30% -40% Oct-21 Nov-21 Dec-21 Jan-22 Feb-22 Mar-22 Apr-22 May-22 Jun-22 Jul-22 Aug-22 Sep-22 Ion Exchange Sensex PRICE DATA (As on 30th September, 2022) SHAREHOLDING PATTERN
Slide 22: Disclaimer
Disclaimer Ion Exchange (India) Limited No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all e
Slide 23: Thank You
THANK YOU